WHO WE ARE
Relentless Focus +
a Balanced Approach =
an Algorithm for Clinical Change That Matters.
New England Venture Capital Association
2020 Emerging MedTech Company of the Year
It always starts with an idea to improve something. With a lot of determination, an idea can turn into an invention, and then evolve into an intervention, or even begin its own ecosystem…forever changing the future of the way something is done.
But the steps to prove out an invention and develop it into clinical practice takes expertise, determination and vision. And that’s what GI Windows is all about.
GI Windows is developing the first fundamental breakthrough in surgical anastomotic technology. This technology will allow less invasive surgery and offer the capability of developing more procedures new to the world. The vision of the GI Windows team is to develop and commercialize a less invasive intervention to help thwart the worldwide epidemic of Obesity & Type 2 diabetes.
The team is made up of experienced individuals who have successfully demonstrated their cross-functional expertise to bring meaningful medical technologies to market. They are committed to innovation that helps improve the way diagnostic and interventional procedures impact the essential balance between both patients and the healthcare system.
Providing less invasive surgical solutions to large global health problems
Our passion is to develop disruptive surgical innovation in the delivery of magnetic compression anastomosis allowing clinicians to improve patient outcomes, reduce healthcare costs by creating new capabilities in healthcare.
Civil & Commercial
Trust, Wills & Probate
“The GI Windows magnets are the first ones capable of creating a compression anastomosis, which, with the help of a common flexible endoscope in a mini-invasive way, could be performed anywhere in the digestive tract accessible by endoscopy. It generates a wide, permanent anastomosis of incredible technical simplicity. This has the potential to change the way we will perform digestive surgery in a not too distant future.”
Dr. Rudolf Buxhoeveden
Chief of Bariatric Surgery
“Type 2 diabetes & obesity create a cascade of risks for patients as it relates to increased cardiac events and increased mortality in a respiratory virus.”
Dr. Christopher Thompson
Director of Endoscopy
Director, Bariatric Endoscopy Fellowship Program
Professor, Harvard Medical School
Gastroenterology, Hepatology and Endoscopy